Request Deal Involvement
Merck to acquire Peloton Therapeutics for $1.05bn, bolstering oncology pipeline.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Centerview Partners
legal advisors
Wilson Sonsini Goodrich & Rosati
financial advisors
Credit Suisse
legal advisors
Covington & Burling
or
Principals
target
PELOTON THERAPEUTICS INC
bidder
MERCK & CO
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite